Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Atlanta Medical Register
|
July 13, 2022
Milk-Sickness
K H Davis
Molecular Pharmacology
|
February 1, 1987
3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors
R A Lyon, K H Davis, M Titeler
JAMA
|
January 28, 1983
Passive inhalation of marijuana smoke and urinary excretion cannabinoids
M Perez-Reyes, S di Guiseppi, K H Davis
Ophthalmic Research
|
January 1, 1982
Orthostatic hypotension after delta 9-tetrahydrocannabinol marihuana inhalation
J C Merritt, C E Cook, K H Davis
JAMA
|
September 23, 1988
Assessment of laboratory quality in urine drug testing. A proficiency testing pilot study
K H Davis, R L Hawks, R V Blanke
Biochemical Pharmacology
|
October 1, 1987
Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand
M Titeler, R A Lyon, K H Davis, et al.
The Journal of Pharmacy and Pharmacology
|
April 1, 1973
Preparation of 9-tetrahydrocannabinol for intravenous injection
J L Olsen, M Makhani, K H Davis, et al.
Experientia
|
November 15, 1973
A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol
M Perez-Reyes, M C Timmons, K H Davis, et al.
British Journal of Sports Medicine
|
July 1, 1980
Blood pressure and rectal temperature responses of middle-aged sedentary, middle-aged active and "A"-grade competitive male squash players
B A Blanksby, B C Elliott, K H Davis, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1983
Passive inhalation of marihuana smoke and urinary excretion of cannabinoids
M Perez-Reyes, S Di Guiseppi, A P Mason, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Atlanta Medical Register
|
July 13, 2022
Milk-Sickness
K H Davis
Molecular Pharmacology
|
February 1, 1987
3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors
R A Lyon, K H Davis, M Titeler
JAMA
|
January 28, 1983
Passive inhalation of marijuana smoke and urinary excretion cannabinoids
M Perez-Reyes, S di Guiseppi, K H Davis
Ophthalmic Research
|
January 1, 1982
Orthostatic hypotension after delta 9-tetrahydrocannabinol marihuana inhalation
J C Merritt, C E Cook, K H Davis
JAMA
|
September 23, 1988
Assessment of laboratory quality in urine drug testing. A proficiency testing pilot study
K H Davis, R L Hawks, R V Blanke
Biochemical Pharmacology
|
October 1, 1987
Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand
M Titeler, R A Lyon, K H Davis, et al.
The Journal of Pharmacy and Pharmacology
|
April 1, 1973
Preparation of 9-tetrahydrocannabinol for intravenous injection
J L Olsen, M Makhani, K H Davis, et al.
Experientia
|
November 15, 1973
A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol
M Perez-Reyes, M C Timmons, K H Davis, et al.
British Journal of Sports Medicine
|
July 1, 1980
Blood pressure and rectal temperature responses of middle-aged sedentary, middle-aged active and "A"-grade competitive male squash players
B A Blanksby, B C Elliott, K H Davis, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1983
Passive inhalation of marihuana smoke and urinary excretion of cannabinoids
M Perez-Reyes, S Di Guiseppi, A P Mason, et al.
Page
of 2